Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutation.

about

Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutation.

Item

http://www.wikidata.org/entity/Q53458479

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Effect of five therapeutic str ...... mbomodulin c.1611C>A mutation.

@en

Effect of five therapeutic str ...... mbomodulin c.1611C>A mutation.

@nl

type

Item

label

Effect of five therapeutic str ...... mbomodulin c.1611C>A mutation.

@en

Effect of five therapeutic str ...... mbomodulin c.1611C>A mutation.

@nl

prefLabel

Effect of five therapeutic str ...... mbomodulin c.1611C>A mutation.

@en

Effect of five therapeutic str ...... mbomodulin c.1611C>A mutation.

@nl

P1476

Effect of five therapeutic str ...... ombomodulin c.1611C>A mutation

@en

P2093

Elisabetta Castoldi

http://www.w3.org/2001/XMLSchema#string

Theo Lindhout

http://www.w3.org/2001/XMLSchema#string

P2860

The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability

A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop)

Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation.

Mechanisms and monitoring of bypassing agent therapy.

Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.

Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.

Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery.

Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels.

P304

993-996

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.13833

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283446033

http://www.w3.org/2001/XMLSchema#string

P698

26517807

http://www.w3.org/2001/XMLSchema#string